Boulder Wealth Advisors’s Amgen AMGN Stock Holding History

Boulder Wealth Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$42K	Buy	+161	New	+$43.2K	0.04%	41

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boulder Wealth Advisors's AMGN Position: Q4 2022 in Review

Boulder Wealth Advisors opened a new position in Amgen (AMGN) in Q4 2022: 161 shares worth $42K. The stake represents 0.04% of the portfolio and ranks #41 among its holdings.

2,502 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

Boulder Wealth Advisors held 161 shares of Amgen worth $42K as of Q4 2022.
Amgen was a new Boulder Wealth Advisors position in Q4 2022.
Amgen made up 0.04% of Boulder Wealth Advisors's portfolio in Q4 2022, its #41 holding.
2,502 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Boulder Wealth Advisors's 13F filing for Q4 2022, filed 21 Feb 2023.